NCT07040137View on ClinicalTrials.gov

Confirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar Degeneration

PHASE3RecruitingINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Spinocerebellar Degeneration
Interventions
DRUG

KPS-0373

Oral administration

DRUG

Placebo

Oral administration

Trial Locations (1)

Unknown

RECRUITING

Research Site, Multiple Locations

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY